Health Conditions

163 conditions with known genetic associations in our database.

Clear
All(163) Other(43,676) Cardiovascular(1,793) Metabolic(1,614) Renal(1,319) Cancer(1,257) Neurological(750) Ophthalmic(535) Gastrointestinal(367) Hematologic(345) Respiratory(323) Autoimmune(265) Dermatologic(221) Pharmacogenomic(163) Musculoskeletal(129)
Estimated Glomerular Filtration Rate (cystatin C)
616 variants Pharmacogenomic
Estimated Glomerular Filtration Rate (creatinine, Cystatin C)
557 variants Pharmacogenomic
Cystatin C Levels
390 variants Pharmacogenomic
Estimated Glomerular Filtration Rate Based On Creatinine and Cystatin C in Bottom 99% of Individuals By Creatinine Levels
382 variants Pharmacogenomic
Cystatin C Levels in Bottom 99% of Individuals By Creatinine Levels
306 variants Pharmacogenomic
S-6-hydroxywarfarin Levels
241 variants Pharmacogenomic
R-warfarin Levels
182 variants Pharmacogenomic
Stable Warfarin Dose
123 variants Pharmacogenomic
Rs-6-hydroxywarfarin Levels
107 variants Pharmacogenomic
Rs-warfarin Levels
87 variants Pharmacogenomic
R-6-hydroxywarfarin Levels
83 variants Pharmacogenomic
Disorders of Intracellular Cobalamin Metabolism
78 variants Pharmacogenomic
S-7-hydroxywarfarin Levels
74 variants Pharmacogenomic
Rs-10-hydroxywarfarin to Rs-warfarin Ratio
73 variants Pharmacogenomic
S-warfarin to R-warfarin Ratio
72 variants Pharmacogenomic
Surfactant Metabolism Dysfunction
72 variants Pharmacogenomic
S-warfarin Levels
69 variants Pharmacogenomic
R-6-hydroxywarfarin to R-warfarin Ratio
68 variants Pharmacogenomic
Rs-10-hydroxywarfarin Levels
64 variants Pharmacogenomic
S-6-hydroxywarfarin to S-warfarin Ratio
59 variants Pharmacogenomic
S-7-hydroxywarfarin to S-warfarin Ratio
55 variants Pharmacogenomic
Abnormality of Metabolism/homeostasis
40 variants Pharmacogenomic
Response to Statin Therapy
38 variants Pharmacogenomic
Cystatin-f Levels
31 variants Pharmacogenomic
Caffeine Metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) Ratio)
29 variants Pharmacogenomic
Vaginal Microbiome Metacyc Pathway (all-chorismate-pwy|superpathway of Chorismate Metabolism)
29 variants Pharmacogenomic
Simvastatin-induced Myopathy
28 variants Pharmacogenomic
Clopidogrel Active Metabolite Levels
27 variants Pharmacogenomic
Pcsk9 Levels in Statin-naive Individuals
27 variants Pharmacogenomic
Warfarin Maintenance Dose
27 variants Pharmacogenomic
Cystatin C Plasma Levels
25 variants Pharmacogenomic
Warfarin Response
19 variants Pharmacogenomic
Cystatin-d Levels
16 variants Pharmacogenomic
Age Related Hearing Loss-related Regional Glucose Metabolism (inferior Colliculus)
15 variants Pharmacogenomic
Disorders of Iron Metabolism (phecode 275.1)
15 variants Pharmacogenomic
Cystatin-sn Levels
14 variants Pharmacogenomic
Age Related Hearing Loss-related Regional Glucose Metabolism (cochlear Nucleus)
13 variants Pharmacogenomic
Kallistatin Levels
13 variants Pharmacogenomic
Warfarin Sensitivity
13 variants Pharmacogenomic
Cystatin C Levels X Vegetarianism Interaction
12 variants Pharmacogenomic
Other Specified Disorders of Plasma Protein Metabolism (phecode 270.38)
12 variants Pharmacogenomic
Unspecified Disorder of Lipoid Metabolism (phecode 272.9)
12 variants Pharmacogenomic
And Impaired Glucose Metabolism 1
11 variants Pharmacogenomic
Caffeine Metabolism (plasma 1,3,7-trimethylxanthine (caffeine) Level)
11 variants Pharmacogenomic
Cystatin-sa Levels
11 variants Pharmacogenomic
Major Depressive Disorder or Glomerular Filtration Rate Estimated From Cystatin (mtag)
11 variants Pharmacogenomic
Poor Metabolism Of
11 variants Pharmacogenomic
Age Related Hearing Loss-related Regional Glucose Metabolism (bilateral Heschl’s Gyrus)
10 variants Pharmacogenomic
Angiostatin Levels
10 variants Pharmacogenomic
Atorvastatin-induced Myopathy
9 variants Pharmacogenomic
Cardiovascular Death or Myocardial Infarction in Response to Clopidogrel Treatment
9 variants Pharmacogenomic
Decline in Glucose Metabolism in Posterior Cingulate Cortex
9 variants Pharmacogenomic
Warfarin Response - Dosage
9 variants Pharmacogenomic
Major Adverse Cardiovascular Events in Response to Aspirin and Clopidogrel Treatment
8 variants Pharmacogenomic
Oncostatin-m Levels
8 variants Pharmacogenomic
Calpastatin Levels
7 variants Pharmacogenomic
Cystatin-c Levels
7 variants Pharmacogenomic
Cystatin-f Levels (cst7.3302.58.1)
7 variants Pharmacogenomic
Lipoprotein-associated Phospholipase A2 Activity Change in Response to Statin Therapy
7 variants Pharmacogenomic
Pcsk9 Levels in Statin-treated Individuals
7 variants Pharmacogenomic
1 2 3 Next »

Upload your DNA to discover which genetic variants you carry and assess your risk.

Get Started Free →